Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early goal-directed plasma volume replacement with balanced gelatin vs balanced crystalloid in severe sepsis/septic shock
2015-000057-20Phase 4Terminated
- Sponsor
- B. Braun
- Start
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of gelatin in septic shock, sepsis and hypovolemia (2 arms), sponsored by B. Braun. Primary endpoint: Time to initial hemodynamic stability. Started Jul 2015; status: terminated.
02
Drugs
gelatin
03
Conditions
septic shocksepsishypovolemia
Beyond the preview
Go deeper on 2015-000057-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000057-20.